BR112021019055A2 - Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios - Google Patents
Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatóriosInfo
- Publication number
- BR112021019055A2 BR112021019055A2 BR112021019055A BR112021019055A BR112021019055A2 BR 112021019055 A2 BR112021019055 A2 BR 112021019055A2 BR 112021019055 A BR112021019055 A BR 112021019055A BR 112021019055 A BR112021019055 A BR 112021019055A BR 112021019055 A2 BR112021019055 A2 BR 112021019055A2
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- treatment
- pharmaceutical compositions
- inflammatory disorders
- methods
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 208000027866 inflammatory disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010016654 Fibrosis Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004761 fibrosis Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios. a presente invenção descreve os compostos de acordo com a fórmula i, em que r1, r2, r5 e cy são como definidos aqui. a presente invenção refere-se aos compostos, métodos para a produção dos referidos compostos, composições farmacêuticas que compreendem os referidos compostos e métodos para a profilaxia e/ou tratamento de doenças inflamatórias, doenças autoimunes, dor, fibrose e/ou doenças proliferativas administrando os referidos compostos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904373.6A GB201904373D0 (en) | 2019-03-29 | 2019-03-29 | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| PCT/EP2020/058064 WO2020200900A1 (en) | 2019-03-29 | 2020-03-24 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021019055A2 true BR112021019055A2 (pt) | 2021-11-30 |
Family
ID=66442982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021019055A BR112021019055A2 (pt) | 2019-03-29 | 2020-03-24 | Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220218679A1 (pt) |
| EP (1) | EP3947378A1 (pt) |
| JP (1) | JP2022526364A (pt) |
| KR (1) | KR20210145238A (pt) |
| CN (1) | CN113646305A (pt) |
| AR (1) | AR118521A1 (pt) |
| AU (1) | AU2020252038A1 (pt) |
| BR (1) | BR112021019055A2 (pt) |
| CA (1) | CA3134736A1 (pt) |
| CO (1) | CO2021014223A2 (pt) |
| GB (1) | GB201904373D0 (pt) |
| IL (1) | IL286677A (pt) |
| MA (1) | MA55497A (pt) |
| MX (1) | MX2021011576A (pt) |
| SG (1) | SG11202110644WA (pt) |
| TW (1) | TW202102501A (pt) |
| WO (1) | WO2020200900A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113243338A (zh) * | 2021-05-14 | 2021-08-13 | 福州大学 | 一种小鼠缺血性卒中模型的构建与评估方法 |
| WO2023116866A1 (zh) * | 2021-12-23 | 2023-06-29 | 杭州多域生物技术有限公司 | 一种五元并六元化合物、制备方法、药物组合物和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2688872A4 (en) * | 2011-03-22 | 2014-08-27 | Merck Sharp & Dohme | AMIDOPYRAZOLHEMMER OF INTERLEUKIN RECEPTOR-MEDIATED KINASES |
| GB201401086D0 (en) * | 2014-01-23 | 2014-03-12 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| BR112018000624A2 (pt) * | 2015-07-15 | 2018-09-18 | Aurigene Discovery Technologies Limited | compostos de indazol e azaindazol como inibidores de irak-4 |
| GB201518456D0 (en) * | 2015-10-19 | 2015-12-02 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases |
| CN109890829B (zh) * | 2016-11-02 | 2022-07-15 | 豪夫迈·罗氏有限公司 | 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物 |
-
2019
- 2019-03-29 GB GBGB1904373.6A patent/GB201904373D0/en not_active Ceased
-
2020
- 2020-03-24 BR BR112021019055A patent/BR112021019055A2/pt unknown
- 2020-03-24 CN CN202080025098.XA patent/CN113646305A/zh active Pending
- 2020-03-24 MX MX2021011576A patent/MX2021011576A/es unknown
- 2020-03-24 CA CA3134736A patent/CA3134736A1/en active Pending
- 2020-03-24 US US17/599,465 patent/US20220218679A1/en active Pending
- 2020-03-24 WO PCT/EP2020/058064 patent/WO2020200900A1/en unknown
- 2020-03-24 MA MA055497A patent/MA55497A/fr unknown
- 2020-03-24 KR KR1020217035254A patent/KR20210145238A/ko active Search and Examination
- 2020-03-24 EP EP20715295.0A patent/EP3947378A1/en active Pending
- 2020-03-24 AU AU2020252038A patent/AU2020252038A1/en not_active Abandoned
- 2020-03-24 SG SG11202110644WA patent/SG11202110644WA/en unknown
- 2020-03-24 JP JP2021557761A patent/JP2022526364A/ja active Pending
- 2020-03-27 TW TW109110404A patent/TW202102501A/zh unknown
- 2020-03-27 AR ARP200100870A patent/AR118521A1/es unknown
-
2021
- 2021-09-26 IL IL286677A patent/IL286677A/en unknown
- 2021-10-25 CO CONC2021/0014223A patent/CO2021014223A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR118521A1 (es) | 2021-10-20 |
| AU2020252038A1 (en) | 2021-11-25 |
| WO2020200900A1 (en) | 2020-10-08 |
| CA3134736A1 (en) | 2020-10-08 |
| MX2021011576A (es) | 2021-10-13 |
| MA55497A (fr) | 2022-02-09 |
| SG11202110644WA (en) | 2021-10-28 |
| EP3947378A1 (en) | 2022-02-09 |
| IL286677A (en) | 2021-10-31 |
| KR20210145238A (ko) | 2021-12-01 |
| CN113646305A (zh) | 2021-11-12 |
| US20220218679A1 (en) | 2022-07-14 |
| GB201904373D0 (en) | 2019-05-15 |
| JP2022526364A (ja) | 2022-05-24 |
| TW202102501A (zh) | 2021-01-16 |
| CO2021014223A2 (es) | 2021-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022010383A2 (pt) | Compostos tricíclicos substituídos | |
| EA202091512A1 (ru) | Производные сульфонилмочевины в качестве модуляторов nlrp3 инфламмасомы | |
| BR112018076534A2 (pt) | compostos heterocíclicos como imunomoduladores | |
| BR112015020998A2 (pt) | compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios | |
| BR112016012734A8 (pt) | composto de 2-amino-6-flúor-n-[5-flúor-piridin-3-il]pirazol[1,5-a]pirimidin-3-carboxamida, formas sólidas, composição, seu uso e processo para a preparação do referido composto | |
| CY1124243T1 (el) | Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1 | |
| BR112017006713A2 (pt) | inibidor de egfr, e preparação e aplicação do mesmo | |
| BR112018067312A2 (pt) | compostos e composições farmacêuticas dos mes-mos para o tratamento da fibrose | |
| BR112016028273A8 (pt) | derivados radiorrotulados de composto de 2-amino6-fluoro-n-[5-fluoro-piridin-3-il]-pirazol[1,5-a]pirimidin3-carboxamida úteis como inibidor de atr cinase, processo para preparação do referido composto, bem como diferentes formas sólidas do mesmo, uso destas, e composição farmacêutica | |
| TR201816176T4 (tr) | Histon deasetilaz 6 inhibitörleri olarak yeni bileşikler ve bunu içeren farmasötik bileşimler. | |
| CR20170187A (es) | 2-Amino-3,5-difluoro-6-metil-6-fenil-3,4,5,6-tetrahidropiridinas en calidad de inhibidores de BACE1 para el tratamiento de la enfermedad de Alzheimer | |
| EA201890767A1 (ru) | C4-модифицированные производные олеаноловой кислоты для ингибирования il-17 и других применений | |
| PH12017500401A1 (en) | Therapeutic compounds as inhibitors of the orexin-1 receptor | |
| BR112022010112A2 (pt) | Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica | |
| BR112012028674A2 (pt) | inibidores de quinase bicíclica fundida | |
| EA201991387A1 (ru) | ТРИЦИКЛИЧЕСКИЕ ЕНОНЫ - ПРОИЗВОДНЫЕ ПИРИМИДИНА ДЛЯ ИНГИБИРОВАНИЯ ROR-γ И ДРУГИХ ПРИМЕНЕНИЙ | |
| EA201891710A1 (ru) | Терапевтические соединения | |
| CY1121063T1 (el) | Αναστολεις της συνθασης της αλδοστερονης | |
| EA202091804A1 (ru) | Гетероциклил-замещенные оксадиазолопиридиновые производные для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) | |
| MX2022000945A (es) | Composicion para incrementar la expresion de pgc-1alfa. | |
| BR112021019055A2 (pt) | Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios | |
| NZ746906A (en) | Oxaborole esters and uses thereof | |
| EA201790070A1 (ru) | Бифениламиды, содержащие модифицированные простые эфирные группы, в качестве ингибиторов hsp90 и стимуляторов hsp70 | |
| BR112015019919A2 (pt) | compostos bicíclicos | |
| BR112021019099A2 (pt) | Compostos e composições farmacêuticas dos mesmos para o tratamento de distúrbios inflamatórios |